Analystreport

Acorda Therapeutics Inc (NASDAQ: ACOR) was upgraded by analysts at Goldman Sachs Group Inc from a "sell" rating to a "neutral" rating.

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors